Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study

Wang, WX; Wang, H; Lu, PH; Yu, ZY; Xu, CW; Zhuang, W; Song, ZB

Song, ZB (reprint author), Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou 310022, Zhejiang, Peoples R China.; Song, ZB (reprint author), Zhejiang Canc Hosp, Dept Chemotherapy, East Banshan Rd, Hangzhou 310022, Zhejiang, Peoples R China.

JOURNAL OF TRANSLATIONAL MEDICINE, 2019; 17 ():

Abstract

BackgroundMET amplification is associated with acquired resistance to first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibit......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索